Biogen heads for the worst day in a decade after ending trial for blockbuster Alzheimer's drug - CNBC
- Biogen heads for the worst day in a decade after ending trial for blockbuster Alzheimer's drug CNBC
- Biogen halts study of Alzheimer's drug, a blow to hopes for new treatment STAT
- UPDATED: Biogen's Alzheimer's drug aducanumab implodes in a PhIII disaster -- putting them at a perilous crossroads Endpoints News
- Biogen Shares Plunge After Alzheimer’s Drug Setback Bloomberg
- Biogen Shares Drop 28% After Ending Alzheimer’s Phase 3 Trials The Wall Street Journal
- View full coverage on Google News
Biogen heads for the worst day in a decade after ending trial for blockbuster Alzheimer's drug - CNBC
![Biogen heads for the worst day in a decade after ending trial for blockbuster Alzheimer's drug - CNBC]()
Reviewed by Geeky Gadgets
on
06:55
Rating:
No comments: